Comparative Effects of Radial and Focused Extracorporeal Shock-wave Therapies in Coccydynia
1 other identifier
interventional
69
1 country
1
Brief Summary
Comparison of the efficacy of coccydynia treatment with two different probes of the ESWT device
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2021
CompletedFirst Submitted
Initial submission to the registry
October 13, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2022
CompletedApril 28, 2022
April 1, 2022
7 months
October 13, 2021
April 27, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analogue Scale
pain evaluation, higher scores mean worse outcome.
1 minute
Oswestry Low Back Pain Disability Questionnaire
higher scores mean better outcome.
5 minutes
Study Arms (3)
Focus extracorporeal shock wave therapy
ACTIVE COMPARATORA total of 4 sessions of ESWT at 1-week intervals were applied to to the sacrococcygeal area
Radial extracorporeal shock wave therapy
ACTIVE COMPARATORA total of 4 sessions of ESWT at 1-week intervals were applied to to the sacrococcygeal area
Sham extracorporeal shock wave therapy
SHAM COMPARATORA total of 4 sessions of ESWT at 1-week intervals were applied to to the sacrococcygeal area
Interventions
Extracorporeal Shock-wave Therapy
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of coccydynia by clinical examination and X-ray imaging.
- be aged ≥18 at the time of diagnosis
- be give informed consent
You may not qualify if:
- Malignancy
- Those who have received ESWT treatment before
- Pediatric patients
- Patients with infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yüzüncü Yıl Üniversitesi Tıp Fakültesi
Van, 65080, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Volkan Şah
Yüzüncü Yıl Üniversitesi Tıp Fakültesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 13, 2021
First Posted
December 14, 2021
Study Start
August 15, 2021
Primary Completion
March 15, 2022
Study Completion
April 27, 2022
Last Updated
April 28, 2022
Record last verified: 2022-04